Skip to content
Aminoscope
Head-to-head

Beta-glucan vs Fucoidan

Two polysaccharides sold for immunity — one from oats or yeast, one from seaweed. The strongest evidence belongs to the form almost nobody buys for immunity.

Beta-glucan

Oat beta-glucan, yeast β-(1,3)/(1,6)-glucan, barley betafiber

Clinical data

Two structurally different molecules share the name: oat/barley β-(1,3)/(1,4) fiber lowers LDL about 0.25 mmol/L at 3 g/day and holds an FDA-authorized health claim, while the yeast/mushroom β-(1,3)/(1,6) form sold for immunity has small, mostly branded-ingredient trials and no authorized claim anywhere.

Full Beta-glucan evidence review

Fucoidan

Oligo-fucoidan, brown seaweed extract

Clinical data

Unusually many real randomized trials for a seaweed supplement — and unusually little depth: roughly one trial each across six unrelated conditions, none replicated. Cancer claims have no human trial behind them.

Full Fucoidan evidence review

Side by side

 Beta-glucanFucoidan
Marketed forCholesterol / heart health, blood sugar, fiber — and separately, 'immune support'Immune support, metabolic health, healthy aging
Evidence gradeClinical dataClinical data
FamilyMetabolic / AMPKImmune & inflammation
Key human sourceWhitehead 2014 meta-analysis of 28 RCTs, Am J Clin NutrPrediabetes RCT, Int J Biol Macromol 2025

marks a row where the two differ. Evidence grades come from our evidence matrix, which grades each molecule on the human data for the use it is marketed for.

Our verdict

Beta-glucan holds the only authorized health claim between them, and it belongs to the oat and barley β-(1,3)/(1,4) fiber for LDL cholesterol — about 0.25 mmol/L at 3 g/day across 28 randomized trials. The yeast and mushroom β-(1,3)/(1,6) form actually sold for immunity has small, mostly branded-ingredient trials and no authorized claim anywhere. Fucoidan has an unusual number of real randomized trials for a seaweed supplement and unusually little depth behind them: roughly one trial each across six unrelated conditions, none replicated, and no human trial supporting the cancer claims. They have not been compared with each other.

Beta-glucan fits if

Cholesterol is the target, you are buying oat or barley beta-glucan specifically, and you will take the 3 g/day the trials used.

Fucoidan fits if

You are following the early metabolic signal and accept a literature that is a trial wide and a trial deep.

Related comparisons